Showing results (711-720 of 791) with videos related to
Sort By:
Pageof 80
JAMA|January 4, 2018
Effect of Mechanically Expanded vs Self-Expanding Transcatheter Aortic Valve Replacement on Mortality and Major Adverse Clinical Events in High-Risk Patients With Aortic Stenosis: The REPRISE III Randomized Clinical TrialTed E Feldman, Michael J Reardon, Vivek Rajagopal, et al.American Journal of Human Genetics|March 19, 2024
Mono-allelic KCNB2 variants lead to a neurodevelopmental syndrome caused by altered channel inactivationShreyas Bhat, Justine Rousseau, Coralie Michaud, et al.Journal of Lower Genital Tract Disease|March 16, 2012
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancerDebbie Saslow, Diane Solomon, Herschel W Lawson, et al.Journal of Genetic Counseling|September 4, 2019
Yield of whole exome sequencing in undiagnosed patients facing insurance coverage barriers to genetic testingChloe M Reuter, Jennefer N Kohler, Devon Bonner, et al.Journal of the American College of Cardiology|March 7, 2023
3-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic StenosisJohn K Forrest, G Michael Deeb, Steven J Yakubov, et al.The American Journal of Cardiology|January 22, 2025
Comparative Outcomes of Left Main and Nonleft Main Percutaneous Coronary Intervention from the Excellence in Coronary Artery Disease (XLCAD) RegistryRobert C Stoler, Minseob Jeong, Talha Akram, et al.Journal of Medical Genetics|September 23, 2008
Microdeletion/duplication at 15q13.2q13.3 among individuals with features of autism and other neuropsychiatric disordersD T Miller, Y Shen, L A Weiss, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 11, 2021
Heterozygous loss-of-function variants significantly expand the phenotypes associated with loss of GDF11Thomas A Ravenscroft, Jennifer B Phillips, Elizabeth Fieg, et al.Lancet (London, England)|September 10, 2017
Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trialWarner K Huh, Elmar A Joura, Anna R Giuliano, et al.American Journal of Human Genetics|November 24, 2020
Heterozygous Variants in KDM4B Lead to Global Developmental Delay and Neuroanatomical DefectsAnna R Duncan, Antonio Vitobello, Stephan C Collins, et al.Pageof 80